Voloridge Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165K | Sell |
31,000
-511,522
| -94% | -$2.72M | ﹤0.01% | 1129 |
|
|
2025
Q1 | $4.81M | Buy |
542,522
+423,301
| +355% | +$3.75M | 0.02% | 788 |
|
|
2024
Q4 | $1.63M | Buy |
+119,221
| New | +$1.63M | 0.01% | 972 |
|
|
2024
Q3 | – | Sell |
-84,660
| Closed | -$2.07M | – | 1296 |
|
|
2024
Q2 | $2.07M | Sell |
84,660
-2,051
| -2% | -$50.2K | 0.01% | 942 |
|
|
2024
Q1 | $1.85M | Sell |
86,711
-12,401
| -13% | -$264K | 0.01% | 873 |
|
|
2023
Q4 | $1.9M | Buy |
+99,112
| New | +$1.9M | 0.01% | 843 |
|
|
2021
Q3 | – | Sell |
-149,831
| Closed | -$4.58M | – | 1785 |
|
|
2021
Q2 | $4.58M | Sell |
149,831
-34,996
| -19% | -$1.07M | 0.03% | 677 |
|
|
2021
Q1 | $5.63M | Buy |
184,827
+41,148
| +29% | +$1.25M | 0.04% | 488 |
|
|
2020
Q4 | $2.84M | Sell |
143,679
-116,060
| -45% | -$2.29M | 0.02% | 622 |
|
|
2020
Q3 | $3.39M | Sell |
259,739
-247,131
| -49% | -$3.22M | 0.03% | 555 |
|
|
2020
Q2 | $5.75M | Buy |
506,870
+476,653
| +1,577% | +$5.41M | 0.07% | 319 |
|
|
2020
Q1 | $432K | Buy |
+30,217
| New | +$432K | 0.01% | 755 |
|
|
2019
Q1 | – | Sell |
-24,023
| Closed | -$698K | – | 1020 |
|
|
2018
Q4 | $698K | Sell |
24,023
-64,198
| -73% | -$1.87M | 0.03% | 304 |
|
|
2018
Q3 | $4.06M | Buy |
88,221
+131
| +0.1% | +$6.03K | 0.09% | 161 |
|
|
2018
Q2 | $3.29M | Buy |
+88,090
| New | +$3.29M | 0.09% | 217 |
|
|
2018
Q1 | – | Sell |
-36,710
| Closed | -$1.26M | – | 597 |
|
|
2017
Q4 | $1.26M | Buy |
+36,710
| New | +$1.26M | 0.03% | 355 |
|